Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Abstract: This article addresses the problem of secure recursive state estimation for a networked linear system, which may be vulnerable to interception of transmitted measurement data by ...

Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...

This LWG issue has LEWG status, so I'm creating an issue here for LEWG to track it. SG1 recommended NAD, if LEWG agrees we'll close the LWG issue.

There was an error while loading. Please reload this page.

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

Indonesian auteur Kamila Andini's latest project 'Four Seasons in Java' won two prizes at the inaugural Tokyo Gap-Financing ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...